Laila Barrak is a dedicated researcher in medical sciences with a strong academic and professional background in biotechnology, health engineering, and molecular biology. She has pursued extensive education, including PhD-level studies at Qatar University (2021–2023), where she completed 42 credits toward a PhD in Medical Sciences. Her earlier academic achievements include degrees in biotechnology (BSc and MSc) from Abdelmalek Essaâdi University in Morocco and a Bachelor's in Chemical, Health Engineering, and Biomaterials from Paris-Sorbonne University.
Professionally, Laila has held multiple research assistant roles, primarily at Qatar University, where she contributed to projects focused on cardiac diseases, genetic mutations, and molecular mechanisms. She also has experience in nanotoxicology and microbial studies from earlier roles in France and Morocco. Her technical expertise includes molecular biology techniques such as PCR, Western blotting, ELISA, and protein expression.
Currently, she works remotely as a Research Assistant at Qatar University and serves as an AI Generative Models Trainer in Biology for Outlier (USA), focusing on prompt generation and AI response evaluation. She also reviews scholarly articles for American Heart Journal Plus.
Laila has published several peer-reviewed papers on genetic mutations linked to cardiac diseases and has presented her work at various academic conferences. Her awards include a graduate assistantship at Qatar University and recognition for academic excellence in France and Morocco.
Cardiac arrhythmias, Congenital heart disease in adults, Coronary heart disease, Critical care medicine, Heart failure, Heart transplantation, Hypertension, Lipid disorders